RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/21944757http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/21944757http://www.w3.org/2000/01/rdf-schema#comment"Peptide nucleic acids (PNAs) bind duplex DNA in a sequence-specific manner, creating triplex structures that can provoke DNA repair and produce genome modification. CCR5 encodes a chemokine receptor required for HIV-1 entry into human cells, and individuals carrying mutations in this gene are resistant to HIV-1 infection. Transfection of human cells with PNAs targeted to the CCR5 gene, plus donor DNAs designed to introduce stop codons mimicking the naturally occurring CCR5-delta32 mutation, produced 2.46% targeted gene modification. CCR5 modification was confirmed at the DNA, RNA, and protein levels and was shown to confer resistance to infection with HIV-1. Targeting of CCR5 was achieved in human CD34(+) hematopoietic stem cells (HSCs) with subsequent engraftment into mice and persistence of the gene modification more than four months posttransplantation. This work suggests a therapeutic strategy for CCR5 knockout in HSCs from HIV-1-infected individuals, rendering cells resistant to HIV-1 and preserving immune system function."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.org/dc/terms/identifier"doi:10.1016/j.chembiol.2011.07.010"xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Kumar P."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Shultz L.D."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Greiner D.L."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"del Campo J."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Kutsch O."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Glazer P.M."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Leif J."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Bindra R."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Rogers F.A."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Schleifman E.B."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/author"Uchil P."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/date"2011"xsd:gYear
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/name"Chem Biol"xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/pages"1189-1198"xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/title"Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids."xsd:string
http://purl.uniprot.org/citations/21944757http://purl.uniprot.org/core/volume"18"xsd:string
http://purl.uniprot.org/citations/21944757http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/21944757
http://purl.uniprot.org/citations/21944757http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/21944757
http://purl.uniprot.org/uniprot/#_A0A089G6S6-mappedCitation-21944757http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21944757
http://purl.uniprot.org/uniprot/#_A0A089G6S9-mappedCitation-21944757http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21944757
http://purl.uniprot.org/uniprot/#_A0A089G7F7-mappedCitation-21944757http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21944757
http://purl.uniprot.org/uniprot/#_A0A089G7G0-mappedCitation-21944757http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21944757